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Acute renal failure is broadly defined as “an abrupt and sustained  decrease in kidney  
function”.  Clinical signs include a rapidly decreasing glomerular filtration rate  (GFR),  
resulting in disturbances in electrolyte- and acid-base balance, derangement of extra cellular  
fluid volume, retention of nitrogenous waste products and often a decreased urine output1.   
The epidemiology of acute renal failure (ARF) has changed over the years. This may 
partly be caused by a change in patient characteristics, but more importantly, by a change in 
definition of the disease. Recent research emphasizes the clinical importance of less severe 
impairment  of  kidney function, resulting in the broader term  acute kidney injury  (AKI). It  
needs to be  stressed:  acute kidney  injury  is a common clinical problem  in critically  ill  
patients and is associated with significant morbidity  and  a  high mortality  rate2. Historically, 
some  researchers  have argued  that patients die with  AKI - not of  AKI – arguing that it 
merely  denotes an expression of illness severity; but now strong evidence backs up the 
notion that  AKI has an independent impact on outcome, even after all other variables 
affecting outcome  has been corrected for3,4,5,6. 
The confusion on how best to assess kidney function include what markers that best 
reflect it, and what values of those markers discriminate normal from abnormal kidney 
function.  To bring clarity  to the field, the Acute Dialysis Quality  Initiative (ADQI ) devised 
the RIFLE classification7. The acronym RIFLE defines three grades of increasing severity of 
AKI (risk, injury, and  failure,  respectively,  R,  I, and F)  and two outcome variables (loss 
and end-stage kidney  disease, respectively, L and E).  
More recently, the Acute Kidney Injury Network (AKIN) group, an international 
collaboration of  nephrologists  and  intensivists, have  proposed refinements to the RIFLE 
criteria8.  Specifically, the AKIN group sought  to increase the sensitivity  of  the RIFLE 
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criteria by recommending that a smaller increase in serum creatinine ( ≥0.3 mg/dl) be used as 
a threshold to define the presence of AKI and identify patients with Stage 1 AKI (analogous 
to RIFLE-Risk) (Table 1). This modification should be seen in the  light of  recent findings, 
demonstrating that small increases in serum creatinine are associated with increased 
mortality9,10. Second, a time constraint of 48 h for the diagnosis of AKI was proposed. Finally, 
any patients  receiving renal replacement therapy were  to now be classified as Stage 3 AKI 
(RIFLE-Failure).   
A   study  by  Bagshaw and co-workers evaluated the AKIN and RIFLE criteria  side 
by  side,  in a  multicenter database study of 1,20,123 critically ill patients. They found that, 
compared to the RIFLE criteria, the newly proposed AKIN criteria do not materially improve 
the sensitivity, robustness or predictive ability of the definition and classification of AKI in 
the first 24 h after  admission to the intensive care unit (ICU), and conclude by writing: 
“There would appear to  be no justification at present for the introduction of a modified 
definition and classification  system for AKI.”  A comparison of the RIFLE and AKIN 













Table 1. A comparison of the RIFLE and AKIN definition and classification schemes for 
AKI 
RIFLE Category Serum creatinine criteria UO criteria 
(A)The acute dialysis quality initiative (ADQI) criteria for the definition and classification of 
AKI (i.e. RIFLE criteria) 
Risk Increase in serum creatinine>1.5x 
baseline or decrease in GFR > 25% 
< 0.5mL/kg/h > 6h 
Injury Increase in serum creatinine> 2.0x 
baseline or decrease in GFR >50% 
< 0.5mL/kg/h > 12h 
Failure Increase in serum creatinine> 3.0x 
baseline or decrease in GFR >75% or 
an absolute serum 
creatinine >354µmol/L with an acute 
rise of at least 44µmol/L 
< 0.3mL/kg/h > 24h or 
anuria > 12h 
AKIN  criteria  Serum creatinine criteria UO criteria 
(B) The proposed Acute Kidney Injury Network (AKIN) criteria for the definition and 
classification of AKI  
Stage 1 Increase in serum creatinine> 
26.2µmol/ L or increase to > 150 -
199% ( 1.5 – 1.9 fold)  from baseline  
< 0.5mL/kg/h > 6h 
Stage 2 Increase in serum creatinine to 200 -
299% ( > 2 – 2.9 fold)  from baseline 
< 0.5mL/kg/h > 12h 
Stage 3 Increase in serum creatinine to > 
300% (> 3 - fold)  from baseline or 
serum creatinine > 354µmol/ L with an 
acute rise of at least 44µmol/ L  or 
initiation of RRT  
< 0.3mL/kg/h > 24h or 
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REVIEW OF LITERATURE 
 
ARF is a devastating illness that is associated with a high risk of mortality.  Despite 
several decades of clinical experience with acute renal failure, the advent of newer antibiotics, 
vastly improved dialytic techniques, an impressive growth in the availability of vasoactive 
drugs and aggressive nutritional support, the mortality rate of ARF has shown only a modest 
improvement over the last few decades.  Bisenbach et al 11   in an analysis of 710 cases over a 
period of 15 years, observed a reduction in the overall mortality from 70 % in 1975-79 to 48 % 
in 1985-89.  However, Forts et al 12 noted a mortality of 46 % which did not change 
significantly over a period of 12 years. 
The unchanged mortality in acute renal failure has been attributed to many reasons.  
First there has been a change in the population susceptible to ARF12 Previously, the patients 
were predominantly young quite often from the armed forces or women of fertile age, 
whereas now  it is more frequent among older patients 11. Secondly, there have been new 
development in medical techniques and aggressive interventions which can maintain people 
alive, who would previously have died before having time to present with ARF 13.  The 
appearance of multiple organ system failure has contributed to a situation in which life can be 
prolonged and maintained indefinitely by artificial means in a patient who will inexorably die 
after lengthy suffering.  
The most precise way of establishing the vital prognosis of an entity is by 
determination of its mortality rate.  Acute renal failure continues to have a high mortality and 
it varies according to the setting in which ARF developed.  In a general setting, the mortality 
is upto the tune of 40-50 %, whereas, it reaches up to 90% in the ICU setting 17, 24   The fact 
that mortality in ARF is very high has interested many authors to conduct studies of factors 
predicting the outcome in ARF.   
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Numerous studies have been conducted both prospectively and retrospectively, and 
various prognostic factors have been proposed to predict the outcome in ARF patients.  Some 
of the studies have been performed in specific situations like ARF following aortic aneurysm 
surgery, 14 post traumatic ARF 15 and ARF in the ICU setting. 16, 17 
There is considerable variability in study designs, ranging from large 25 to small 
retrospective series26.  Inclusion criteria vary, ranging from mild increased in creatinine to 
only dialysis treated patients 21.  Still fewer studies18,19,20 focus, even in part, on the 
epidemiology of ARF requiring dialysis within the ICU (severe acute renal failure of critical 
illness). The need for both dialysis and ICU care defines a specific group of critically ill 
patients who may have a particularly poor prognosis18,21,22 and who consume vast amounts of 
resources23. Information on the overall incidence, style of management, and patient outcome 
would be useful in assessing current therapeutic approaches, research and resource allocation, 
and future therapies. 
 Another feature of modern studies is that factors found non contributory on univariate 
analysis  can be contributory in multivariate analysis and conversely, factors predictive on 
univariate analysis may be redundant on multivariate analysis.     
Denominators of survival in ARF patients 
 Multiple denominators of survival in patients with ARF have been proposed but none 
of them has been generally accepted or has not been challenged by others.  Little prospective 
information on independent predictors identified by appropriate multivariate analysis is 






I. Patients characteristics 
(a) Cause of ARF 
 The cause of ARF will serve as a strong predictor of survival.  There is abundant 
evidence that the causes of ARF affecting younger patients like war victims and obstetric 
causes carrying excellent prognosis are decreasing.  At the same time, causes of ARF with 
poor prognosis like hypotension and sepsis have increased in the elderly people.21   Turney et 
al 25  in a study of 1347 patients with severe acute renal failure treated at a single centre 
between 1956 and 1988, observed that there was decline in obstetric and traumatic causes, 
both of which carried an excellent prognosis and there was an increase in the number of 
elderly patients with complicated medical and surgical conditions.  A similar observations 
was also made by Beaman et al 27 and Chugh et at 28. 
Among medical causes, toxic agents (contrast, aminoglycosides and other drugs) have 
increased and appear to have good prognosis with survival rate of upto 80%. Medical causes 
other than toxic renal damage (sepsis and heart disease) have poorer survival with survival 
rate of 45%29. 
 In a study of prognostic factors  in acute renal failure due to sepsis, Neveu et al 30 
observed that patients with septic ARF were older, had higher organ failure scores at 
inclusion, had a higher need for mechanical ventilation, and mortality was higher in these 
patients when compared to those with non septic ARF.  Mortality was influenced by the 
presence of septic shock or of sepsis syndrome on inclusion.  However, a few studies in 
contrast have failed to show any independent link between sepsis and mortality 28,31,32 
  Series examining surgical patients show survival rates between 19 and 47 % 31,14.  
Discriminant analyses have given conflicting results regarding surgery.  Cioffi et al 31 
identified cardiac and vascular surgery (other than on the abdominal aorta) as predictors of 
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mortality while Rasmussen et al 33 observed non cardiovascular surgery to be a predictor of 
mortality.  
Improvements in obstetrical care have led to a virtual disappearance of ARF related to 
pregnancy in the advanced countries. Even in some of the developing countries like India, the 
incidence of obstetric ARF has shown a decline from 22% (of all ARF) in 1960s to 8% in 
1990s 28 . On the other hand, in Ethiopia, septic abortion is the underlying cause of ARF in 52% 
of all patients 72 and in Argentina and Nigeria, gynecologic and obstetric complications still 
account for 32% and 25% of cases of ARF respectively 64,65, . This high incidence is due to 
the prevalence of unsafe home deliveries and abortions conducted by untrained personnel.  
 (b) Setting in which ARF develops 
 In community acquired ARF (CARF) the prognosis usually is excellent.  Kaufman et 
al 34 studied prospectively over 17 months, 100 patients who were admitted to the hospital 
with acute elevation of serum creatinine.  Seventy percent of the patients had prerenal 
azotemia, 11% has intrinsic acute renal failure, 17% has obstruction and 2% could not be 
classified.  Mortality was lowest (7%) in the group with prerenal azotemia.  Volume 
contraction due to vomiting decreased fluid intake, diarrhea, fever or diuretics was the most 
common underlying cause.  The group with intrinsic ARF had the highest mortality (55%) 
with drug-induced ARF and infection-related ARF being the common causes.  The overall 
mortality in this study was 15%.  In a prospective study done by Feest et al 35 of severe ARF 
in adults in the community, an overall survival of 54% was noted at two years.   
 When ARF developed as a nosocomial disease during hospital stay outcome is much 
less favourable.  In a study of risk factors and outcome of hospital acquired ARF36, the 
development of hospital acquired ARF was associated with a marked increase in the risk of 
death- the relative risk being 6.5 and it was associated with marked increase in length of stay.  
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Jha et al 37 in a study of hospital acquired renal failure observed a mortality rate of 41% and 
the death was related directly to the renal failure in 14% of these patient.  Occurrence of renal 
failure during maximum therapeutic support at a critical care unit carries a grim prognosis. 
C) Severity of renal injury : 
 The severity of renal injury has an impact on renal recovery after ARF.  The need for 
renal replacement therapy is associated with a poor prognosis.  Lohr et al 21  in a study of 126 
patients of ARF who received dialysis observed a survival of 25 %.  Patients who had 
systolic blood pressure (SBP) <110 mmHg, assisted ventilation, congestive heart failure, 
proven or suspected sepsis had higher mortality rates and survival decreased with increasing 
number of the above mentioned factors.  Liano et al 29 in a study of 228 patients observed that 
need for dialysis was associated with higher mortality as compared to those not requiring it 
(65% vs.46%).  Abreo et al 38 in a study measuring the outcome of 55 consecutive patients 
requiring haemodialysis (HD), noted an increase in the mortality from 54% to 72%.   
Incidentally the need for dialysis is not an objective criterion because the indications 
to institute haemodialysis may vary considerably between institutions with several units 
favouring early dialysis therapy when BUN levels of about 50mg/dl.  In many instances the 
severity of renal injury will reflect the severity of underlying disease but this is not 
necessarily the case as in nephrotoxic ARF of intrinsic renal disease. 
Serum creatinine at the time of admission or diagnosis of ARF has lacked predictive 
value 26.  However, the peak creatinine level has been found to relate to outcome in more than 
one study 34,39.  This view has also been disputed.  Urea levels (either on admission, at time of 





(d) Urine output 
 Oliguric ARF is associated with higher mortality than non oliguric ARF. In a study of 
Rasmussen et al, 33 oliguria and pre-existing heart disease were the most common predictor 
variables of mortality and was significant at the 0.05 level on univariate analysis. Liano et 
al29 in prospective analysis of 228 cases, observed that oliguria was associated with higher 
mortality (65% vs. 42%) as compared to non oliguric ARF.   
(e) Demographic factors 
There is no consistency in the literature relating age to increased mortality in ARF.  
Because of the various age related changes in kidney function such as decrease in glomerular 
function and concentration ability, disturbances of thirst and fluid balance leading to 
hypovolemia, the susceptibility of developing ARF is increased in advanced age and a 
comparatively mild insult will lead to renal shutdown.  Advanced age is associated with 
multiple additional illness such as generalized atherosclerosis, hypertension and diabetes 
mellitus40.  Because of these associated factors Several studies have identified age as an 
adverse prognostic factor in ARF 25, 31.  While others have not found age to be an independent 
predictor of mortality 41,29,34,20.  In a hospital based prospective study on treatment related 
ARF in the elderly  Kohli et al 42 observed that mortality was significantly higher in elderly 
patients with ARF than those without it.   
(f) Organ dysfunction 
The mortality of patients with ARF increases with the number of failed organ systems 
both in ICU and non ICU settings 43. 
Presence of multiorgan failure was associated with increasing mortality in a study by 
Jha et al 37. Chertow et al 18 observed that the  mortality of ARF in patients on a ventilator is 
about 80% and mortality increased with increasing number of failed non respiratory organs.   
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Central nervous system dysfunction has also been associated with poor prognosis29.  GI 
bleeding was not associated with poor prognosis in earlier studies 41,20,32.  
Shock has often been associated with a poor prognosis and was found to  be an 
independent predictor of mortality21,29,20.  Hypotension was found to be an independent 
predictor of mortality using multivariate analysis 21,29,45,20.  
  (g) Comorbidities  
Co-existing diseases not predictive of mortality include diabetes mellitus, 
hypertension, immune deficiencies, dehydration and alcoholism20.  Presence of liver failure 
was not associated with mortality in a number of studies 41,21,29,18.  However, in a large study 
of ARF of Turney et al 25 and in a study of ARF in medical intensive care20, liver failure was 
associated with mortality. 
II.Treatment of ARF 
Studies of therapy in ARF are often uninterpretable because of lack of information on 
the matching of prognostic factors in control and treated patients.       
Central to the treatment of severe ARF is dialysis.  Previously several groups have 
tried to study the effect of the intensity of dialysis on outcome using control populations and 
found no difference in out come.  In a prospective trial by Gillum et al46, the mortality in the 
intensive dialysis group was higher (59%) than in the non intensive group (47%) dialysed to 
keep the predialysis BUN below 100mg /dl. 
Pagnini et al47 recently showed a link between dialysis therapy and outcome in ICU 
patients with ARF; however this link was only present when the underlying co-morbidity was 
taken into account using the Cleveland clinic severity of illness score.  Without factoring for 
co-morbidity, dialysis had no effect on survival. 
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In contrary to the above mentioned notion that intensive dialysis was not associated 
with better outcome, Two separate analysis have reported a better outcome with intensive 
dialysis.  Schiff et al48 recently reported the preliminary results of a trial in 72 critically ill 
patient with ARF who were randomized to either daily or alternative day dialysis using bio-
compatible high flux dialysers.  Overall mortality was significantly improved in the daily 
dialysis group (21% vs.47% for the alternative day group).  When analysed in terms of 
delivered dialysis dose (Kt/V), mortality was 16% in the group receiving  a weekly Kt/V 
greater than 6, which was significantly  less than the 57 % mortality in patients receiving 
under dialysis (weekly Kt/V<3). 
In a recent study of 160 patients with ARF 49, patients were randomized to receive 
either intermittent hemodialysis (IHD) or daily hemodialysis (DHD).  Both the groups were 
comparable with respect to age, sex, cause and severity of acute renal failure, medical or 
surgical intensive care setting and the APACHE Score.  Daily hemodialysis resulted in better 
control of uremia, fewer hypotensive episodes during hemodialysis and more rapid resolution 
of acute renal failure.  The mortality rate, according to intention to treat analysis was 28 % 
for daily dialysis and 46% for alternate day dialysis.  In multiple regression analysis, less 
frequent haemodialysis was an independent risk factor for death. 
Many studies have compared the mode of dialysis in determining the outcome of ARF 
patients.  Prospective randomized trials are difficult to perform because hemodynamically 
unstable patients cannot tolerate haemodialysis, while it may be ethically problematic to 
confine a hemodyanamically stable patient to bed while receiving continuous renal 
replacement therapy (CRRT).  A prospective trial from Barcelona failed to find any 
difference in survival 50. 
In a multicenter, randomized controlled trial comparing two dialysis modalities 
(intermittent (IHD) vs. continuous hemodiafiltration) for the treatment of ARF in the 
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intensive care unit (ICU) 106 patients were randomised51.  Continuous therapy was 
associated with an increase in ICU and in hospital mortality relative to intermittent dialysis.  
Despite the potential advantages of continuous techniques, this study produced no evidence 
of a survival benefit of continuous hemodiafiltration compared with IHD. However, despite 
randomization there were significant differences between the groups in several covariates 
independently associated with mortality including gender, hepatic failure, APACHE II and III 
scores and the number of failed organ systems, in each instances biased in favour of the 
intermittent dialysis group. 
Laboratory Parameters 
Potassium levels, sodium, hemoglobin, thyroid function have not been shown to be 
good predictors of outcome whereas metabolic acidosis, low platelet count, high bilirubin are 
significantly associated with high mortality4,19,61,105 . 
Index of Severity  and  Mortality 
With the cost of medical care increasing tremendously, the need for assessing the 
prognosis and explaining it to the family becomes very pertinent to the treating physician.  
Various scoring systems, mostly illness severity scores, have been developed to optimize the 
use of clinical experience in the intensive care unit and to address questions of effectiveness, 
efficiency, quality of care and correct allocation of scarce resources.  These indices also allow 
comparison of different units and randomization in clinical trials. 
The general scoring systems are, however, inappropriate for disease specific 
populations such as patients in ARF.  Since ARF creates an additional risk of mortality, 
disease specific scoring systems have been developed.  One such was proposed by Liano et 
al52.  Most of the severity scores available are complicated and require complex calculations. 
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Of the various severity scores described to measures the severity of ARF, APACHE II 
is the most widely used, both in ICU and non ICU settings.  The APACHE II score53 is the 
sum of three components, an acute physiological score (APS) where twelve variables 
including the Glasgow coma scale are considered, an age related score and chronic health 
evaluation score (CHE). Scores range from 0-71 with higher values having a worse prognosis.  
The APS is based on the worst physiological values during the first 24hours of admission.  
Though APACHE II is easier to use, it underestimates the risk of mortality of patients with 
acute renal failure.22 APACHE II scores don’t work because the proportion of the score 
allocated to renal failure is only 4% which de-emphasises the independent mortality risk of 
ARF.  APACHE II scoring however was found promising in a retrospective analysis.  No 
patients with APACHE score of more that 40 survived.  However when APACHE score 
analysed prospectively did not predict the outcome16. 
However Parker et al54 in a prospective multicenter  controlled study concluded that 
the use of APACHE II score at the time of initiation of dialysis for patients with ARF is a 
statistically significant predictor of patient survival and recovery of renal function. 
Fernandes et al 55 compared the performance of the APACHE II score with that of 
Acute Tubular Necrosis – individual severity score (ATN-ISS) proposed by Liano et al52.  
Similar data are obtained from APACHE and ATN – ISS score for both ICU and non ICU 
patients.  Thus, they concluded that APACHE II score collected at hospital admission or at 
the time of referral to nephrologists and ATN-ISS score can be used as a severity of illness 
score . 
Another scoring used in the ICU setting is version II of the Simplified Acute 
physiology score (SAPS II).56 It is derived from 12 physiological variables, age, type of 
admission and three underlying variables.  The resulting SAPS II score is then entered into a 
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published mathematical formula in which the solution gives the mathematical value of the 
predicted hospital mortality. 
Recently Fiaccadorki et al 57 in a prospective study compared three general severity of 
illness scoring systems in predicting patient outcome from acute renal failure.  (APACHE II, 
SAPS II and Version II of the mortality probability model at 24hours ( MPM24 II).  The 
APACHE II model was a slightly better calibrated predictor of group outcome in ARF 
patients as compared with the SAPS II and MPM24 II outcome prediction models. The 
MPM24IImodel showed the best discrimination capacity, in comparison with both APACHE 
II and SAPSII, but it constantly and significantly overestimated mean predicted mortality.  
However none of the models provide sufficient confidence for the prediction of outcome in 
individual patients. 
Recently ARF specific severity index scores have been developed for all patients with 
ARF 52 and ICU patients with ARF 21 
Liano et al52 have developed an accurate index that has been validated retrospectively 
and prospectively in several different populations.  The index accurately predicted overall 
mortality in ICU and non-ICU ARF.  Renal dysfunction accounts for 21% of the index and 
co-morbid illness accounts for the remainder.  It also indicates the individual contributions of 
oliguria, hypotension, jaundice, coma and assisted ventilation.  The biggest component is 
assisted ventilation which agrees with previous studies that have indicated the 80% mortality 
of those developing ARF while on a ventilator.  
Drawbacks of the scoring systems  
Most of the scoring systems described above are suitable for ICU setting and work 
quite well in the hospital in which they were developed but failed when extrapolated to other 
settings.  The most widely used of the above, APACHE II has traditionally been performed at 
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the time of admission to ICU whereas the prognosis of patients with ARF requiring dialysis 
may best be determined at the time of dialysis initiation.58.  Moreover, oliguira, which is an 
important predictor of outcome in ARF patients, has not been included among the variables.  
In developing countries like India, with meager resources, younger patients requiring ICU 
admissions are preferred over the elderly with similar co- morbid conditions.  Younger age 
may be criterion for pre-selection of patients for admission to the ICU. Considering the above 





























AIMS AND OBJECTIVES 
The aims of the study were: 
a) To determine prospectively the variables predicting the outcome of patients with 
severe acute renal failure requiring haemodialysis admitted during a one year period. 
























MATERIALS AND METHODS  
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MATERIALS AND METHODS 
This study was conducted over a 1 year  period (November 1, 2010– October 31, 
2011) in  patients admitted to the PSG IMSR  who satisfied the following criteria  :- 
All patients admitted with severe ARF during the study period. Severe ARF was 
defined as any degree of ARF, which, in the opinion of the treating physician, required the 
commencement of renal replacement therapy. 
Exclusion criteria: 
Patients who had received RRT for indications other than ARF like, prevention of 
contrast nephropathy and drug poisoning; Known end-stage renal disease (ESRD) patients 
who had been receiving chronic renal dialysis before admission; Patients having been started 
on RRT for ARF in other units before  admission.  End stage renal Disease was defined as 
GFR <15 ml/min/1.73 m2 body surface area estimated by the Cockcroft- Gault equation i.e. 
KDOQI stage 5 or dialysis dependency 
The Institutional Human Ethics Committee approved the study protocol. 
A  Prestructured Proforma was developed for the purpose of the study and the 
following information was obtained: Age, sex, date of admission to hospital and details of 
ICU or non ICU (ward) , patients history, physical examination and laboratory investigations   
on the day of admission , premorbid renal function, and serum creatinine  at the time of 
initiation of haemodialysis. The main cause of acute renal failure (hypotension/ischemia, 
sepsis, septic shock, rhabdomyolysis, nephrotoxins, radiocontrast, other) was made according 
to the judgment of the clinician. Other investigations to look for the cause of renal failure 
were performed according to clinical assessment.  Other Information obtained prior to the 
start of renal replacement of therapy such as the use of mechanical ventilation, ionotropic / 
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vasopressor drugs, the serum creatinine and bilirubin values, the Glasgow coma score,  and 
urinary output for the preceding 24 h.  
Information was also obtained on patient outcome, hospital mortality, number of days 
of renal replacement therapy, patients who developed ESRD, and duration of hospital stay 
renal Intermittent HD Was the RRT modes used in all the patients A double – lumen catheter 
was used for vascular access in all cases. The femoral position was chosen in 80 (70.2%) 
patients, and the jugular in 34 patients (29.8%). The Polysulfone Diacap (Low Flux 1.2m2, 
KUF 7.9 B Braun Germany) membrane was used in all patients. The approach to 
anticoagulation was dependant on patient coagulation profile with either heparin free or 
intermittent heparin as advised by clinician.   
  Renal biopsy was performed on patients in whom the cause of ARF was not clear at 
the outset or if renal failure due to glomerular disease, renal failure not improving after 3 
months of treatment. 
Patients were classified as oliguirc or non oliguric based on lowest daily urine output 
during the azotemic phase.  Oliguria was defined as a urine volume less than 400ml/day. 
Causes of renal failure were classified as follows: 
Medical: a) All cases of acute tubular necrosis with a medical cause  b) Intrinsic renal 
disease patients with glomerulonephritis, vasculitis, haemolytic uremic syndrome etc. 
Surgery: Those patients who had predominantly surgical cause for admission and those 
subsequently developed ARF following road traffic accidents. 




In order to assign a possible cause for ARF, following criteria were applied: 
Sepsis was considered to be present when two or more of the following were present 
as a result of systemic infection. (i) temperature > 38 o C or < 36 o C (ii) heart rate > 90/mt 
(iii) respiratory rate > 20/mt or Pa CO2 < 32 mm and (iv) WBC > 12000/mm3, <4000/mm3 
or <20 % band form 59.   
Organ dysfunction   
We recorded the organs and systems that had failed at the time  of initiation of hemodialysis 
according to the following criteria, which were defined in the PROWESS study 60 :  
Cardiovascular: Shock: systolic arterial pressure ≤90 mmHg or mean arterial pressure ≤70 
mmHg, during at least 1 hour despite adequate resuscitation with fluids or adequate 
intravascular volume; or use of vasopressors (dopamine ≥5 µg/Kg/minute; noradrenaline or 
adrenaline at any dose; dobutamine was not taken into account). Unexplained metabolic 
acidosis (pH <7.30 or base excess ≤-5 mmol/l) associated with an arterial lactate 
concentration ≥ 2 mmol/l with no other apparent cause. 
 Respiratory: mechanical ventilation; or PaO2/FiO2 <250 mmHg if other organ dysfunction 
was present; or PaO2/ FIO2 < 200 mmHg if only pulmonary dysfunction was present.  
Nervous system: encephalopathy with GCS <13 without sedation unexplained by other 
causes.  
Liver: bilirubin >3 mg/dl or increase in prothrombin time related to a hepatic cause. 
Hematological: platelets <80,000/ml3 or decrease of 50% in the 3 previous days.  
Stopping of hemodialysis: is considered if serum creatinine <3, normal serum electrolytes 




 The outcome measured was hospital mortality, patients who developed ESRD. 
Relationship between demographics, premorbidities and clinical parameters with above 
outcome measures were studied.  
The influence of various factors such as (1) age of patient (2) premorbidities like (i) cardiac, 
(ii) Liver failure, (iii) hypertension and (iv) diabetes (3) serum creatinine at the time of 
admission and at the time of initiation of dialysis (4) presence or absence of oliguria (5) 
Presence of organ dysfunction (6) Major  cause of acute renal failure  (7)  duration of dialysis 
on the outcome of acute renal failure patients were analysed. 
STATISTICAL ANALYSIS 
Data were expressed as number of patients (%) for categorical data or mean ± standard 
deviation (SD) for numerical data unless specified. Fisher’s exact test was used for 
categorical data and Mann-Whitney U test and student t test for continuous data in univariate 
analysis with survivors and non survivors as dependent variable. A p value of less than 0.05 
was considered as significant. Multivariate analysis was performed using survivors and non 
survivors as dependent variable. Multiple logistic was performed for organ dysfunction. Data 















OBSERVATIONS & RESULTS  
21 
 
OBSERVATIONS & RESULTS 
One hundred thirty eight patients developed severe acute renal failure requiring acute 
renal replacement therapy during the 12-mo study period from 1st November 2010 to 31st 
October, 2011. Among these, 24 patients were excluded. Reasons for exclusion were (not 
mutually exclusive): 3 received RRT for indications other than ARF (eg drug poisoning); 5 
had underlying ESRD; 4 patients were started RRT for ARF from other units before 
admission. In 12 patients outcome could not be ascertained, as they were either discharged on 
request or left against medical advice before recovery.  These patients were excluded from 
the analysis of outcome. Finally, the data of 114 patients were analyzed.  
 Table 2 shows the demographic variables of our study population 
The mean age of these patients was 52.95 + 15.75 (range 18-89 years).   The total 
number of males were 72 (63.2%) and 42 were females (36.8%).  Of these patients 84 (73.7%) 
got admitted in ICU and 30(26.3%) in ward. 
Pre morbid disease at the time of presentation included cardiovascular disease in 16 
(14%), liver disease in 11 (9.6%), hypertension in 21 (18.4%), diabetes mellitus (DM) in 34 
(29.8%),preexisting chronic renal disease in 10 (8.8%)patients. 
Of the 114 patients, 96(84.2%) were admitted under medical, 16(14%) under   
surgical   and 2 (1.8%) under obstetric specialities.   
Sepsis contributed to ARF in 46 patients (40.4%), Hypovolemic shock in 11 patients 
(9.6%), Hepatorenal syndrome in 11 patients (9.6%) Cardiogenic shock in 10 patients (8.8%) , 
acute glomerulonephritis   in 7 (6.1%), Obstructive renal failure  in 6 patients(5.3%) ,drug 
related ARF, malaria, acute pancreatitis, following major surgery in 4 patients each(3.5%), 
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post CABG, snake bite, rhabdomyolysis in 2 patients each (1.8%),pregnancy related ARF in 
1 patient (0.9%). 
   The mean creatinine in the study population was 5.36 + 2.78 mg/dl .The mean 
duration of hospital stay was 12.09 + 8.23 days with a range of 2-50days. The mean duration 
of hemodialysis was 12.81+ 18.2 days. 
      Of the 114 patients, 49 died (42.98%), 61 (53.5%) recovered to have normal renal 
functions or mild renal dysfunction not requiring hemodialysis during follow up and 4 
patients (3.5%) progressed to end state renal disease (ESRD) .   
 In non ICU (ward) patients , the mortality is 6 (12.2 %) , whereas, it is  43 (87.8%) in 
the ICU setting .   
Univariate Analysis 
 The following observations were made on univariate analysis (Table 3). 
Premorbidities:  
Chronic liver disease was seen in 11 patients (9.6%), of whom 9 patients died (81.8%).  
Mortality in those without liver disease was 40 (38.8%).  This difference was statistically 
significant for mortality(p 0.008)).  
Preexisting cardiac disease was seen in 16 patients (14%), of whom 10 patients died (62.5% ).  
Mortality in those without preexisting cardiac disease was 39 (39.8%).  However this 
difference was not statistically significant for mortality (p>0.05).  
Presence of diabetes was not significantly associated with mortality.  A total of 34 patients 





Preexisting renal disease was seen in 10 patients (8.8%), of whom 1 patient died 
(10%) .  Mortality rate among those with pre-existing   renal disease was not significant. 
         Hypertension was seen in 21 patients (18.4%), of whom 7 patients died (33%).  
Mortality rate among those with preexisting renal disease was not significant  
Cause of ARF 
Presence of sepsis was not associated with significantly poor outcome (p>0.05).  Of 
the 46 (40.4%) patients with sepsis, 20 died (43.5%) whereas 29 (42.6%) who did not have 
sepsis at admission died. 
Hypovolemic shock at the time of admission was observed in 11 patients (9.6%). Two 
(18.2%) out of the eleven patients expired whereas 47 patients who did not have hypovolemic 
shock died (45.6%).  Presence of hypovolemic shock was thus not associated with higher 
mortality.   
Hepatorenal syndrome   was observed in 11 patients (9.6%). 9(81.8%) out of the 
eleven patients expired whereas 40 patients who did not have hepatorenal syndrome died 
(38.8%).  Presence of hepatorenal syndrome was significantly associated with higher 
mortality (p<0.05).   
Cardiogenic shock at the time of admission was observed in 10 patients (8.8%).  Eight 
(80%) out of the ten patients expired whereas 41 patients who did not have cardiogenic shock 
at the time of presentation died (39.4%).  Presence of cardiogenic shock was thus associated 
with higher mortality (p<0.05).   
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Acute glomerulonephritis   was observed in 7 patients (6.1%). one(14.3%) out of the 
seven patients expired whereas 48 patients who did not have primary renal disease died 
(44.9%).  Presence of primary renal disease was thus not associated with higher mortality. 
Renal failure secondary to acute pancreatitis, and malaria was seen in 4 (3.5%) 
patients each and mortality associated with these diseases was not significant. 
Renal failure secondary to snake bite and major surgery was seen in 2 and 4 patients 
respectively and all these patients expired. 
Other aetiologies like obstruction, nephrotoxic medications, post CABG, 
rhabdomyolysis, and pregnancy related renal disease were not associated with any mortality. 
ARF was oliguiric in 97 patients (85.1%) and non oliguric in 17 patients (14.9%).  49 
of the oliguirc patients (50.5%) died whereas none of the nonoliguric patients died.  
Univariate analysis revealed significant difference between the two groups (p<0.05). 
Requirement of Mechanical Ventilator support was observed in 44 
patients(38.6%)and  34 (77.3%) of them  expired whereas 15 patients (21.4%) not requiring 
Mechanical ventilation died.  Univariate analysis revealed significant difference between the 
two groups (p<0.05). 
Requirement of Ionotropic support was observed in 59 patients(51.8%)and  41 (69.5%) 
of them were expired whereas 8 patients (14.5%) not requiring Ionotropic support died. 
Univariate analysis revealed significant increase in mortality among that requiring ionotropic 
support. (p<0.05). 
The  GCS score   of <8 was present in 18 patients out of which 16 patients died and 




Stepwise Multiple regression has been performed to check the impact of the organ 
dysfunction present at the time of initiation of hemodialysis . (Table 5,5a). Factors such as 
Creatinine, GCS, Platelet Count, Bilirubin, Syst BP<90 mm of Hg, Mech Ventilation on the 
dependent variable i.e., Survivor or Non survivor. From the above table 5  it is clear that 
when platelet count is entered, it shows an impact of 4%  , when Mech Ventilation and 
Platelet Count is taken  it shows an impact of 31%, when Syst Bp<90 mm of Hg, Platelet 
Count and Mech Ventilation Is taken for study it shows an impact of 38.9%, when serum 
Bilirubin, Mech Ventilation, Platelet Count and Syst BP<90 mm of Hg is taken for study it 
shows an impact of 43.8%, when GCS, Platelet Count, serum Bilirubin, Syst BP<90 mm of 
Hg and Mech Ventilation is taken for study it shows an impact of 48.1%, when Creatinine, 
GCS, Platelet Count, serum Bilirubin, Syst BP< 90 mm of Hg and Mech Ventilation is taken 
for study it shows an impact of 48.1%  
When all the variables are taken for the study, the Beta values and Significant values 
are listed in the above table 5a. From the study it is clear that out of the six variables taken for 
study, SYST BP<90 mm of Hg,  Bilirubin and GCS shows significant relationship with the 
dependent variable of Survivor or Non Survivor 
Among other factors analysed, age, sex was not significantly different between the 
survivors & nonsurvivors.  
Mean peak serum creatinine at the time of initiation of dialysis was also significantly 
higher among survivors (5.62 ± 2.72 mg/dl vs. 5.01 ± 2.84 mg/dl). Mean serum bilirubin at 
the time of initiation of dialysis was significantly higher among nonsurvivors (5.95 ± 7.79 
mg/dl vs. 1.73 ± 2.3 mg/dl). Mean arterial lactate at the time of initiation of dialysis was 
significantly higher among nonsurvivors (6.91 ± 4.96 mg/d vs. 2.27 ± 1.94 mg/dl) Mean 
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platelet count at the time of initiation of dialysis was significantly lower among nonsurvivors 
(1, 61,142. 85± 1, 05,188.32   vs. 216843.75 ± 131184.37). (TABLE 6) 
            The mean duration of hospital stay among survivors not requiring hemodialysis was 
14.06 +7.38, survivors with ESRD was 11+ 4.08and non survivors was 9.73 + 8.93 days.  
The mean duration of dialysis among survivors who recovered renal function and not on 
hemodialysis was 12.41 ± 12.66 days vs. 7± 7 days among non survivors .    
The following factors were associated with hospital mortality by univariate analysis: 
history of chronic liver disease causes of ARF like cardiogenic shock, hepatorenal 
syndrome,use of vasopressors and mechanical ventilation,low urine output,serum creatinine , 
bilirubin,lactate,platelet count at the time of initiation of haemodialysis. The results are 
summarized in Table 3,6 
Multivariate analysis 
Multivariate analysis was performed (Table 7).  Parameters directly related to ARF 
and found significant association with mortality were chronic liver disease, preexisting heart 
disease, requirement of mechanical ventilation, oliguria, sepsis, cardiogenic shock, admission 
in ICU. 
Of those patients who survived, 61 (53.5%) recovered to have normal renal functions 
or mild renal dysfunction not requiring hemodialysis on follow up and 4 (3.5%) progressed to 
ESRD.  These two groups were separately analysed (Table 8). 
Among males 3 of the total 65 (4.6%) survivors developed end stage disease (ESRD).  
Among females 1 (1.5%) of the 65 survivors developed ESRD.  Of those patients who 
developed ESRD all had medical causes of ARF.  None of those with surgical, obstetric 
causes progressed to ESRD. 
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Among the causes of ARF, sepsis, hypovolemic shock ,cardiogenic shock, pigment 
nephropathy, toxic nephropathy,obstruction,pancreatitis,pregnancy related ARF,malaria,post 
CABG and AIN did not predict the occurrence of ESRD.  However, those patients who were 
diagnosed to have acute glomerulonephritis as the cause of ARF were more prone to ESRD (, 
p<0.05)). 
The mean age of the patients who developed ESRD did not differ from those who 
recovered renal functions completely (44.5±8.18 years vs. 52.62±15.7 yrs p>0.05).  The 
duration of dialysis, as expectedly was significantly different between the two groups 
(90±00days and 12.41±12.26 days, p<0.05). 
Peak serum creatinine was 5.59±2.79 mg/dl in patients who recovered and 5.97±1.34 
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TABLES & FIGURES 

























TOTAL  114 
MEAN AGE (yrs) 52.95 ± 15.75 





Cause of ARF  
Sepsis (%) 46(40.4%) 
Hypovolemic shock  11(9.6%) 
Cardiogenic shock  10(8.8%) 
Hepatorenal syndrome 11 (9.6%) 
Acute glomerulonephritis 7 (6.1%) 
Drug induced renal failure 4 ( 3.5%) 
Acute Pancreatitis 4 (3.5%) 
Malaria  4 (3.5%) 
Snake Bite  2 (1.8%) 
Obstructive Renal failure  6 (5.3%) 
Following major surgery  4 (3.5%) 
Post CABG 2 (1.8%) 
Rhabdomyolysis  2 (1.8%) 
Pregnancy Related  1 (0.9%) 
Mean Duration of Hospital stay( days) 12.09 ± 8.23 
Duration of Dialysis  (days) 12.81 ± 18.2 
Oliguria: Non oliguria  97:17 
ICU:NON ICU 84:30 
Mean Serum Creatinine 5.36 ± 2.78 
OUTCOME  
Non survivors 49 





Table 3  Total population co morbidities, cause of renal failure, organ failure (Fishers 
Exact test) 
















Diabetes 34 80 25 73.5 40 50.0 9 26.5 40 50.0 0.016 
Hypertension 21 93 14 66.7 51 54.8 7 33.3 42 45.2 0.230 
Heart 16 98 6 37.5 59 60.2 10 62.5 39 39.8 0.077 




10 104 9 90.0 56 53.8 1 10.0 48 46.2 0.026 
            
Sepsis 46 68 26 56.5 39 57.4 20 43.5 29 42.6 0.541 
Hypovolemic 
shock 
11 103 9 81.8 56 54.4 2 18.2 47 45.6 0.073 
Heart failure 10 104 2 20.0 63 60.6 8 80.0 41 39.4 0.016 
Hepatorenal 
Syndrome 




7 107 6 85.7 59 55.1 1 14.3 48 44.9 0.115 
Acute 
Pancreatitis 
4 110 2 50.0 63 57.3 2 50.0 47 42.7 0.578 
Malaria 4 110 3 75.0 62 56.4 1 25.0 48 43.6 0.422 
Snake bite 2 112 0 0.0 65 58.0 2 100.0 47 42.0 0.183 
Drug induced 
renal failure 
7 107 1 100.0 64 56.6 0 0.0 49 43.4 0.570 
Obstructive 
renal failure 
6 108 6 100.0 59 54.6 0 0.0 49 45.4 0.031 
Following 
major surgery 
4 110 0 0.0 65 59.1 4 100.0 45 40.9 0.032 
Post CABG 2 112 2 100.0 63 56.2 0 0.0 49 43.8 0.323 
Rhabdomplysi
s 
2 112 2 100.0 63 56.2 0 0.0 49 43.8 0.323 
Pregnancy 
related 
1 113 1 100.0 64 56.6 0 0.0 49 43.4 0.570 
            
Urine output 97 17 48 49.5 17 100.
0 
49 50.5 0 0.0 0.000 
VASOACTIV
E DRUGS 
59 55 18 30.5 47 85.5 41 69.5 8 14.5 0.000 
Mech 
Ventilation 




TABLE 4 Relationship between GCS & Survivor or Non survivor  
GCS Score Survivor Non Survivor Total P value 
Less than or equal to 8 2(3.1%) 16(32.7%) 18(.8%) 0.000 
9-12 8(12.3%) 24(49.0%) 32(28.1%) 
More than or equal to 13 55(84.6%) 9(18.4%) 64(56.1%) 
Total 65(100.0%) 49(100.0%) 114(100.0%) 
 
TABLE 5  Multiple regression analysis 
Variables Entered R R Square Adjusted R Square 
Platelet count 0.225 0.051 0.042 
Mech Ventilation, Platelet Count 0.568 0.322 0.310 
Syst BP<90 mm of Hg, Platelet 
Count, Mech Ventilation 0.637 0.406 0.389 
Bilirubin, Mech Ventilation, Platelet 
Count, Syst BP<90 mm of Hg 0.677 0.458 0.438 
GCS, Platelet Count, Bilirubin, Syst 
BP<90 mm of Hg, Mech Ventilation 0.710 0.504 0.481 
Creatinine, GCS, Platelet Count, 
Bilirubin, Syst BP<90 mm of Hg, 
Mech Ventilation 
0.714 0.509 0.481 
 
 











Sig.  B Std. Error Beta 
1. (Constant) 2.626 0.178  14.730 0.000 
Platelet Count -4.289E-7 0.000 -0.106 -1.495 0.138 
Mech 
ventilation 
-0.119 0.106 -0.117 -1.119 0.266 
Syst BP<90 
mm of Hg 
-0.254 0.096 -0.256 -2.640 0.010 
Bilirubin 0.017 0.007 0.198 2.624 0.010 
GCS -0.054 0.019 -0.331 -2.835 0.005 
Creatinine 0.014 0.014 0.081 1.053 0.295 
 
a. Dependent Variable: Survivor or Non survivor 
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TABLE 6 Mann Whitney U tests 
 
 Survivor Non Survivor Total P value 
Hb (Mean ± SD) 11.13 ± 2.23 11.43 ± 2.83 11.26±2.51 .826 
TLC(Mean ± SD) 15658.46±6398.65 20602.04±12730.81 17783.33±9903.36 .012 









S.Sodium(Mean ± SD) 133.49±7.14 131.84±8.24 132.7807 ±7.65 .203 
S.Potassium(Mean ± SD) 4.64±1.26 5.04±1.42 4.81±1.34 .119 
Arterial PH(Mean ± SD) 7.29±.078 7.20±.132 7.25±0.11 .000 
Arterial Lactate(Mean ± 
SD) 
2.27±1.94 6.91±4.96 4.26±4.23 .000 
S. Creatinine(Mean ± 
SD) 
5.62±2.72 5.01±2.84 5.36±2.78 .045 
S. Bilirubin(Mean ± SD) 1.73±2.30 5.95±7.79 3.55±5.75 .000 

















Table : 7  Variables predicting outcome in total population (Multivariate analysis) 
Factor  B Sig 
Age -.020 .170 
Sex  -.418 .278 
Cormorbidities    
Diabetes -.656 .095 
Hypertension .142 .750 
Heart disease 2.131 .026 
Liver disease -5.601 .000 
Preexisting chronic  
renal disease .073 .885 
ARF Cause   
Sepsis 3.035 .000 
Hypovolemic 
shock  1.875 .026 








glomeulonephritis .250 .784 
Drug induced renal 
failure 2.876 .033 
Acute Pancreatitis 2.638 .073 
Malaria .004 .997 
Snake bite 13.073 .990 
Obstructive renal 
failure 1.385 .179 
Following major 
surgery 14.861 .963 
Post CABG 4.186 .020 
Rhabdomplysis 5.044 .001 
Pregnancy related 7.223 .000 
Ward 1.098 .010 
Mechanical 
Ventilation -3.559 .000 
Vasoactive drugs -.079 .869 







       Table : 8 All survivors Characteristics (Mann whitney u test and Student t-test) 
 Recovered ESRD P value 
Age(Mean ± SD) 52.62 ± 15.70 44.50 ± 8.18 .257 
Sex (n %)    
Male 35(57.4) 3(75.0) .496 
Female 26(42.6) 1(25.0) 
Pre morbidities (n %)    
Diabetes(n %)    
0.631 Yes 23(37.7) 2(50.0) 
No 38(62.3) 2(50.0) 
Hypertension (n %)    
Yes 11(18.0) 3(75.0) 0.007 
No 50(82.0) 1(25.0) 
Heart disease(n %)    
Yes 6(9.8) 0(0.0) 0.518 
No 55(90.2) 4(100.0 
Liver disease (n %)    
Yes 2 (3.3) 0 (0.0) 0.718 
No 59(96.7) 4(100.0) 
Preexisting chronic renal 
disease(n %) 
   
Yes 9(14.8) 0(0.0) 0.416 
No 52(85.2) 4(100.0) 
Speciality(n %)    
Medicine 48(78.7) 4(100.0) 0.338 
Surgery 11(18.0) 0(0.0) 
OBG 2(3.3) 0(0.0) 
    
ARF Cause(n %)    
Sepsis 26(42.6) 0(0.0) 0.095 
Hypovolemic shock  9(14.8) 0(0.0) 0.416 
Cardiogenic shock  2(3.3) 0(0.0) 0.718 
Hepatorenal Syndrome 2(3.3) 0(0.0) 0.718 
Acute glomerulonephritis 2(3.3) 4(100.0) 0.000 
Drug induced renal failure 4(6.6) 0(0.0) 0.800 
Pancreatitis 2(3.3) 0(0.0) 0.718 
Malaria 3(4.9) 0(0.0) 0.656 
Snake bite  0(0.0) 0(0.0) - 
Obstructive renal failure 6(9.8) 0(0.0) 0.518 
Following major surgery 0(0.0) 0(0.0) - 
Post CABG 2(3.3) 0(0.0) 0.718 
Rhabdomplysis 2(3.3) 0(0.0) 0.718 
Pregnancy related 1(1.6) 0(0.0) 0.800 
Mechanical Ventilation(n %)    
Yes 10(16.4) 0(0.0) 0.387 
 
 



















 Recovered ESRD P value 
Vasoactive drugs(n %)    
Yes 18(29.5) 0(0.0) 0.207 
No 43(70.5) 4(100.0) 
Urine output(n %)    
Yes 44(72.1) 4(100.0)   0.226 
 
 
No 17(27.9) 0(0.0) 
Hospital LOS (days)  
(Mean ± SD) 
14.06 ± 7.38 11.0 ± 4.08 0.450 
Duration of RRT (days) (Mean 
± SD) 
12.41 ± 12.66 90.0 ± 0.0 0.001 
Ward(n %)    
ICU 37(60.7) 4(100.0) 0.118 
No ICU 24(39.3) 0(0.0) 
Hospital LOS (days)  
(Mean ± SD) 
14.06 ± 7.38 11.0 ± 4.08 0.450 
Ward(n %)    
ICU 37(60.7) 4(100.0) 0.118 



































































































































































































 This study was done in prospective manner to determine the variables predicting the 
outcome of ARF requiring hemodialysis, in patients admitted to PSGIMSR over a period of 1 
year ( 1st Nov 2010 to 31st Oct 2011). 
 Etiology of ARF 
        In recent years, improvements in socioeconomic conditions, rapid industrialization, 
expanding medical facilities and developments in the preventive aspects have led to near 
eradication of ARF due to infections and obstetrical causes in the west. 
 ARF in the western societies is now largely a consequence of road traffic accidents, 
cardiovascular surgery, drugs, multi-organ failure and renal transplant rejection 25. This sharp 
decline in the incidence of community acquired ARF in the developed countries contrasts 
with hospitals in tropical countries which continue to cater to ARF associated with diarrheal 
diseases, obstetrical accidents, toxins and infections specific and unique to their respective 
regions, The patterns of ARF encountered in the tropics have, however, shown changes 
similar to those in the west, though at a much slower pace 28 . Amongst the medical causes of 
ARF, etiological factors leading to ARF in tropical countries are very different from those 
seen in the developed world. Diarrheal diseases, intravascular hemolysis due to G6PD 
deficiency, copper sulfate poisoning, snake bites and insect stings together constitute over 40% 
of all causes of ARF in India and these causes are rarely encountered in the west 28,62 . 
Amongst the other important differences is the younger age of patients developing 
ARF in the tropics. In the West, the median age of patients has increased from 41.3 years in 
the 1950s to 60 years in the 1980s 25 . On the other hand, the average patient dialyzed for 
ARF in the tropical countries is younger and is in the 4 th decade of life 63, 64, 65. 
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 Haemodialysis facilities are not widely available in the underdeveloped countries of 
the tropics and even peritoneal dialysis (PD) is available only in the major townships. 
Therefore, it is quite common to see patients presenting with severe and life threatening 
complications of renal failure requiring emergency management including dialysis. Finally, it 
is not uncommon to see patients in the tropics with common and treatable diseases presenting 
with major complications including renal failure simply because of poverty, ignorance and 
inadequate access to medical care. 
A total of 114 (Males 72, Females 42) patients with ARF were seen during the study 
period. Etiologilcally patients were divided into medical (84.2%), Surgical (14%) and 
obstetric (1.8%) groups.  
Although younger age patients develop ARF in the tropics63,64,65 . The mean age of 
our patients was 52.95 +15.75years This was similar to the age group in other studies done by  
Liano et al 29 and  Feest et al 35  
Septicemia was the most common cause of severe ARF in our study which is similar 
to other studies66,67,68,69,70. This information highlights the fact that any successful way of 
decreasing the incidence of severe ARF is likely to be based on the development of more 
effective therapies for the prevention or rapid treatment of sepsis.  
Diarroheal diseases showed a significant decline (9.6%) compared to   previous 
studies28,70 . Similarly Snake bites  was a   common  cause of ARF in the prevous studies but 
our study showed  decreased incidence probably due to tertiary care  and private set up . 
The incidence of surgical ARF in our centre is 16(14%) patients and obstructive 
Uropathy form stones are the most frequent aetiology. This is similar to study done by 
Sakhuja etal71   in which ARF due to obstructive uropathy constitutes a major cause of 
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surgical ARF. Trauma and operative complications contribute to only 2-5% of cases of 
community-acquired ARF in the tropics. Whereas road traffic accidents, drugs, complicated 
cardiac, vascular and abdominal surgeries are the leading causes of surgical ARF in 
developed countries. 
            Improvements in obstetrical care have led to a virtual disappearance of ARF related to 
pregnancy in the advanced countries. Even in some of the developing countries like India, the 
incidence of obstetric ARF has shown a decline from 22% (of all ARF) in 1960s to 8% in 
1990s 28 . On the other hand, in Ethiopia, septic abortion is the underlying cause of ARF in 52% 
of all patients 72 and in Argentina and Nigeria, gynecologic and obstetric complications still 
account for 32% and 25% of cases of ARF respectively 64,65 . This high incidence is due to 
the prevalence of unsafe home deliveries and abortions conducted by untrained personnel. 
The  obstetric patients with severe ARF   in the our  study was 2  (1.8%) ; and they are 
increasingly rare elsewhere as well 16,73,74 However this may not be the true incidence in india 
as ours is a single centre and private set up where a limited number of patients would have 
been seen.  
The patterns of ARF encountered in our study have, however, shown changes similar to those 
in the west, though at a much slower pace where the age of patients was old age with multiple 
comorbodities . Sepsis was the predominant cause of ARF and diarrhoea as cuse of severe 
ARF decreased and decline in obstetric causes and increasing surgical causes of ARF 
Outcome  
Acute renal failure continues to have a high mortality .Despite several decades of 
clinical experience with acute renal failure, the advent of newer antibiotics, vastly improved 
dialytic techniques, an impressive growth in the availability of vasoactive drugs and 
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aggressive nutritional support, the mortality rate of ARF has shown only a modest 
improvement over the last few decades.   
Mortality varies according to the setting in which ARF developed.  In NON ICU 
patients, the mortality is  upto the tune of 40-50 %, whereas, it reaches upto 90% in the ICU 
setting  17,24.   In our study mortality in patients admitted in ICU was (87.8%) than patients 
admitted in non ICU (ward) (12.2%)  
Analysis revealed increased age among the non-survivors but not statistically 
significant.  Increasing age has been identified as an adverse prognostic factor in many 
studies.  25,21,39,32,76,77,78,79,80.  Presence of an increasing number of co-morbid conditions like 
diabetes, atherosclerosis with advancing age may contribute to the poor survival. However, 
some others demonstrated that patient's age does not worsen the outcome of ARF17, 81, 82, 83.  
Despite some previous studies which observed a trend towards an increasing number 
of ARF cases among male patients compared to female patients75 and also showed male 
gender to be an effective factor on ARF mortality76, in our study no significant difference was 
found between sex and ARF outcome 
Among the causes leading to ATN  sepsis  was associated with poor outcome in 
previous studies84,85,41,16,86,25,87,73,74 . Sepsis contributes to mortality by its associated 
cardiopulmonary failure. As has been well delineated in several other reports, this syndrome 
is associated with a poor prognosis; improved methods to treat multiorgan failure may benefit 
these patients.88, 89 and traditional hemodialysis techniques have not helped to improve the 
outcome of ARF in such patients. In our study outcome of sepsis causing renal failure was 
not significant in univariate analysis however it was significant in multivariate analysis 
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          Previous studies have examined cardiac morbidity as a prognostic factor, but results 
have been contradictory. Some have found an association with mortality21, 31,81,84,90 whereas 
others have not24, 41. It is difficult to compare these studies because of a wide variation in the 
definition of "cardiac failure," including hypotension, CHF, infective endocarditis, 
myocarditis, arrhythmias, and myocardial infarction. At least three prior studies have found 
CHF specifically, rather than the broadly defined "cardiac failure," to be a risk factor for 
hospital mortality in ARF. Lien and Chan evaluated 58 patients retrospectively and found 
CHF, not specifically defined, to be associated with increased mortality by univariate (RR = 
1.9), but not multivariate analysis 84. Lohr, McFarlane, and Granthan retrospectively 
evaluated 126 patients with ARF and found CHF, defined as characteristic radiographic 
appearance, rales, decreased cardiac output, or the presence of a third heart sound, to have a 
significantly increased risk of mortality (RR = 1.3) 21. In our study ATN due to cardiogenic 
shock secondary to acute myocardial infarction, acute decompensated cardiac failure was 
associated with poor outcome 
   In our study Hepatorenal syndrome as a cause of ARF was seen in 11 (9.6%) patients 
of which 9 patients (81.8%) died and was statistically significant .The BEST study 2 also 
demonstrated that hepatorenal syndrome was independent risk factors for hospital mortality. 
The pathology involved in the development of hepatorenal syndrome is thought to be an 
alteration in blood flow and vascular tone that supplies the splanchnic circulation and the 
kidneys98. The structure of the kidneys are basically normal, and the kidneys often function 
instantly well if the liver disease is corrected e.g. by liver transplantation. Hepatorenal 
syndrome carries a poor prognosis and is usually fatal99.  
In our study acute glomerulonephritis was seen in seven patients (6.1%) of which only 
one patient died and 4 patients developed ESRD. Presence of glomerular disease as a cause of 
ARF was associated with significantly better survival.  The presence of other poor prognostic 
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factors like sepsis and organ system failures were less compared to the rest of the population. 
A better survival   seen in patients with glomerular causes leading to ARF is in agreement 
with other studies 25. 
Mortality rate was elevated among severe ARF patients due to snake bite who were 
treated with RRT (91). The recovery of ARF in snke bite is associated with shorter mean bite 
to needle time as was observed by Sharma et al 92, less bleeding manifestations as noticed by 
Soe et al 93 and intravascular hemolysis and elevated serum ceatinine as stated by Kalantri et 
al. 94 All of our patients treated with RRT expired though it is not the case in other studies  
where most patients of snake bite with severe renal failure.  The high mortality in our study 
could be explained by probably being tertiary care centre only seriously ill snake bite patients 
would have been referred to us. 
In our study 4 patients had acute pancreatitis of which 2 patients died. Presence of 
pancreatitis adversely affects the outcome by mortality and requires longer duration of RRT.  
This observation was in accordance with that of Rasmusseno et al 33.  Presence of lesser 
number of patients with the above illness may explain the statistically insignificant results 
obtained, in spite of high mortality 
Patients with myoglobinuric renal failure and obstructive uropathy tended to have a 
better prognosis, but the small numbers of patients in such categories made it impossible to 
assign statistical significance to this observation95 
In our study diabete mellitus was present in 34 patients (29.8%) out of which 9 
patients died (26.5%).Similar to the observations of many other studies 20,21,29,96 presence of 
diabetes mellitus was not significantly associated  with increased mortality.     
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Of 114 patients, 10(8.8%) had pre-existing chronic renal disease. After evaluating the 
effect of underlying CRD on the outcome of ARF, it is revealed that there is no statistically-
significant relationship between   prognosis of ARF and pre-existing CRD as a risk factor. A 
recent study determined underlying renal pathology as a leading precipitating cause for renal 
failure97. 
Presence of hypotension at the time of admission was associated with a poor outcome.  
This is in agreement with the results of other studies, where presence of hypotension was 
significantly associated with mortality 21, 29, 96 . Hypotension when present is usually 
associated with sepsis and multiorgan dysfunction syndrome thereby explaining the poor 
prognosis.  
Oliguria has been associated with poor survival in many studies 16, 33, 41,29,37,42.  Our 
results were also similar, in that oliguric ARF had higher mortality than non-oliguric ARF 
(50.5 % vs. 0%, P<0.05).  In our study 49.5% of the patients with oliguria survived and 100% 
of nonoliguric patients survived. Corwin et al 41observed a survival of 83% among those with 
non oliguric ARF as compared to 42% of oliguric patients.  Liano et al 29 noted that 65% of 
oliguric patients died against a mortality of 42% among non-oliguric patients.   
Prognosis of patients who developed organ system dysfunction   at the time of 
initiation of hemodialysis was compared to those who did not develop the same. Non-
survivors presented with more organ system dysfunction at the time of initiation of 
hemodialysis  than survivors.  
   In agreement with other studies, CVS dysfunction at the time of ARF was 
associated with a high mortality rate 33, 25,36,38,32.  
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  Presence of hepatic failure at the time of initiation of haemodialysis was associated 
with increased mortality in a few series 84,100, but not in others 21, 32, 39. In our study presence 
of liver failure at the time of initiation of haemodialysis was associated with significant 
mortality 
Patients who present with CNS dysfunction at the time of initiation of haemodialysis 
have been observed to have a poor outcome in some studies 33,29,84.  Univariate analysis 
revealed that the patients who had CNS dysfunction were more prone to death 
 Presence of RS dysfunction and requirement of mechanical ventilation have been 
consistently associated with high mortality 2, 6,25,29,32,33,39,84,101. Several mechanisms were 
hypothesized to explain this finding. First, mechanical ventilation might affect systemic 
haemodynamics through its effect on cardiac output. Second, mechanical ventilation could 
cause baro- and volutrauma, and generated release of systemic inflammatory mediators. 
Third, the need for mechanical ventilation was associated with conditions of greater severity, 
e.g. respiratory failure due to acute pulmonary edema or pneumonia 
Metabolic acidosis  was associated with poor outcome2,4,19,61,102,103,104,105,106. Our data 
suggest that the presence of metabolic acidosis increased the risk of mortality. 
The  mean serum creatinine at the time initiation of  haemodialysis was significantly 
higher in the survivors group.  Conflicting results are found in the literature regarding serum 
creatinine.  A high serum creatinine among the survivors group may be explained by a 
selection bias.  Probably, the patients with low serum creatinine were clinically more ill.  
Since dialysis is based on a clinical judgment rather than the absolute value of serum 
creatinine,  a selection bias may explain the low serum creatinine among non-survivors.   
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 The incidence of ESRD among patients who recovered was 6.1%. In a study done by 
Bonomini et al 107 observed ESRD in 16.2% of the survivors.  Patients with acute 
glomerulonephritis especially those with rapidly progressive glomerulonephritis more often 
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SUMMARY AND CONCLUSION 
One hundred and fourteen patients who were diagnosed to have ARF requiring 
haemodialysis during the study period and were analysed prospectively to (1) determine the 
variables predicting the outcome of acute renal failure   (2) study the aetiology. 
 Medical causes contributed to ARF in 84.2%, surgical causes in 14% and obstetric 
causes in 2% of patients. 
Among the causes of ARF, sepsis contributed predominantly (40.4%), followed by 
hypovolemic shock hepatorenal syndrome in 9.6% each. 
Observations made on the analysis of the whole population  
          A mortality rate of 42.98% was noted in this study, another 53.5% patients recovered 
to normal renal function or mild renal dysfunction but not requiring hemodialysis during 
follow up, 3.5% patients survived but progressed to ESRD.  Patients admitted in ICU had 
higher mortality.  
           Renal failure was oliguric in 85.1% and non oliguirc in 14.9%. Olguirc renal failure 
was associated with poorer outcome. 
Results obtained on univariate analysis of the role of co existing diseases and organ 
system failures are as follows. The following factors were associated with hospital mortality 
by univariate analysis: history of chronic liver disease causes of ARF like cardiogenic shock, 
hepatorenal syndrome, use of vasopressors and mechanical ventilation, low urine 
output,serum creatinine , bilirubin, lactate, platelet count at the time of initiation of 
haemodialysis.  
           Multivariate analysis was performed   and parameters directly related to ARF and 
found significant association with mortality were chronic liver disease, preexisting heart 
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disease, requirement of mechanical ventilation, oliguria, sepsis, hepatorenal syndrome 
cardiogenic shock, admission in ICU. 
ARF leading to ESRD 
1. Among the survivors, 3.5% progressed to ESRD. 
2. Among the causes leading to ARF, patients diagnosed to have acute 
glomerulonephritis and were more likely to develop ESRD. 
3. No other parameters, including gender, age, oliguria, , co-existing diseases, and organ 
dysfunction prior to the development of ARF , predicted progression to ESRD. 
Limitation 
As this was an observational study, drawing cause-andeffect conclusion between 
various factors and the outcomes was difficult. Also, it was only a single-centre study; the 
result may not be generalizable as different centres could have different causes and 
approaches in the management of ARF. In this study we did not separate the patients with 
severe ARF into hospital acquired or community acquired. 
Conclusion 
Our study showed that ARF patients requiring RRT was associated with high hospital 
mortality, Multivariate analysis was performed   Parameters directly related to ARF and 
found significant association with mortality were chronic liver disease, preexisting heart 
disease, requirement of mechanical ventilation, oliguria, sepsis, hepatorenal syndrome  
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PROFORMA FOR ACUTE RENAL FAILURE 
S. No:  Cr No: Admission no: 
Name:         OP.NO: 
D.O. Admn: D. O. Disch:  D.O.Death: 














RISK FACTORS, On 
admission 
 LABORATORY DATA / 
ON ADMISSION 
 
Demographics  Hb  
Age  TC, N  
Male/ Female gender  Platelets   
Comorbidity / Duration   RBS/FBS/PPBS  
Diabetes Mellitus  Urea/ Creatinine  
Hypertension  Sodium/ Potassium  
Liver disease  Ionised  Calcium  
Pre-existing heart disease  Metabolic acidosis –PH,   
Pre existing chronic renal 
disease 
   





  High bilirubin  
    
Diagnosis    
Sepsis / Septic shock Source      
    
Medical Patients  TREATMENT  
Surgical Patients  Mechanical ventilation  
Obstetric Patients  Vasoactive medication  
    
ORGAN FAILURE    
Oliguria  Pulse  
Hypotension requiring 
ionotrops  
 BP  
GCS score   RR  
Respiratory Failure  Temperature  
Heart failure    
Liver failure    
Number of organ failure    
Severity of renal injury   Treatment   
 Oliguria  - Duration before 
initiation of dialysis 
 Site of catheter   
  Starting of HD (Date  
Creatinine level  At the time  of 
initiation of dialysis 
 Stopping of HD (date)  
  Total duration of HD  
  Date of recovery of renal failure  
Urine:   Albumin  PCR  RBC   WBC      Bacteria  
Immunological                              ANA:           ANCA:  ANTI GBM:  
Miscellaneous: 
Renal Biopsy 
Date          
Urea           





















SODIUM POTASSIUM PH LACTATE
MECH   
VENTILATION
VASOACTIVE    
DRUGS SYST BP<90 CREATININE
1 10/48558 RAJ KUMAR 50 Male ICU Absent Present Present Absent Present 13.8 10500 168000 136 4.3 7.34 0.8 Absent Absent Absent 2.8
2 10/48997 MOHAMMED 38 Male Not ICU Absent Absent Absent Absent Absent 12.9 10900 242000 137 4.5 7.3 2 Absent Absent Absent 6
3 10/49461 SHANMUGAM 50 Male Not ICU Absent Absent Absent Absent Absent 12.3 20000 145000 127 4.7 7.2 6 Absent Absent Absent 3.1
4 10/40081 MEENAKSHI 70 Female ICU Absent Absent Present Present Present 13.3 18900 332000 132 4.9 7.34 2 Absent Absent Absent 5.2
4 10/50351 VEERAPPA GOUNDER 75 Male ICU Absent Absent Absent Absent Absent 10.5 15100 119000 132 5.8 7.3 2.8 Absent Present Present 5
6 10/51345 NACHAMMA 81 Female ICU Absent Absent Absent Absent Absent 8.2 8400 425000 133 5.6 7.34 1 Absent Absent Absent 10
7 10/51492 SHANMUGAM 45 Male ICU Absent Absent Present Present Absent 11 6200 184000 137 3.9 7.4 0.8 Absent Absent Absent 5
8 10/52082 MUTHULAXMI 55 Female ICU Absent Absent Absent Absent Absent 9.7 9400 351000 141 3.1 7.3 0.8 Absent Absent Absent 8.1
9 10/51580 REHNA  BEGUM 57 Female ICU Absent Absent Absent Absent Absent 14.5 17500 265000 135 3.9 7.2 2 Present Present Present 3.2
10 10/52583 VARADAMBAL 54 Female ICU Absent Absent Absent Absent Absent 6.1 18600 152000 133 6.8 7.2 2.1 Present Present Present 8.6
11 10/52260 CHELLAMUTHU 42 Male ICU Absent Absent Absent Absent Absent 10.2 20000 52000 138 3.6 7.2 6 Present Present Present 4
12 10/52593 KANAGARAJ 37 Male Not ICU Absent Absent Absent Absent Present 12.6 9600 332000 138 6.2 7.34 0.8 Absent Absent Absent 15
13 10/52610 PARVATHY 37 Female ICU Absent Absent Absent Absent Absent 17 29800 178000 138 4.9 7.2 12 Present Present Present 3.6
14 10/52000 PALANISAMY 61 Male Not ICU Absent Absent Present Absent Absent 11 10000 106000 133 4.4 7.24 4 Absent Absent Absent 5.4
15 11/00892 KUPPATHAL 71 Female ICU Absent Absent Present Present Present 11 16600 409000 142 2.2 7.1 0.7 Absent Present Present 5.1
16 11/02566 CHALLATHAL 65 Female ICU Absent Absent Present Present Present 10.4 10400 320000 122 8 7.4 1.2 Absent Absent Absent 2.07
17 11/05180 RAJALAXMI 55 Female Not ICU Absent Absent Present Absent Absent 8.4 21500 136000 126 5 7.4 0.8 Absent Present Present 5.4
18 11/02762 MUTHUSAMY 30 Male ICU Absent Absent Absent Absent Absent 13.5 14700 179000 133 3.3 7.3 0.8 Absent Absent Absent 8.9
19 11/00358 KRISHNAMMAL 77 Female ICU Absent Present Present Present Absent 10.2 20700 361000 136 5.5 7.1 10 Present Present Present 2.7
20 10/51492 SHANMUGAM 45 Male ICU Absent Absent Present Present Absent 11 6200 184000 137 3.9 7.4 0.8 Absent Absent Absent 5.9
21 10/49996 AYYAMMAL 65 Female ICU Absent Absent Present Absent Present 6.2 18000 93000 135 4.8 7.34 2.5 Absent Absent Absent 4.8
22 10/50148 GOPINATHAN 71 Male ICU Absent Present Present Absent Absent 10.6 13500 160000 135 4.5 7.1 5.6 Absent Present Present 4.5
23 10/50378 CHENNIYAPPA GOUNDAL70 Male Not ICU Absent Absent Absent Absent Absent 9.5 15700 88000 140 4.2 7.3 2 Absent Absent Absent 11.8
24 11/04316 SUSHEELA 42 Female ICU Absent Absent Absent Absent Absent 13.9 19200 235000 140 3.7 7.2 4 Absent Absent Absent 4.3
25 11/04830 GNANASEKAR 28 Male ICU Absent Absent Absent Absent Absent 12 16800 140000 138 6.6 7.2 2 Present Absent Absent 9.3
26 11/04199 KEMBIYAN 70 Male ICU Absent Absent Absent Present Absent 11.9 19200 290000 131 3.9 7.3 1.7 Absent Absent Absent 3.9
27 11/05126 PARIMALA 43 Female ICU Absent Absent Absent Absent Absent 8.8 17700 159000 130 7.1 7.34 0.8 Present Absent Absent 7.2
28 11/03145 PAUL RAJ 61 Female Not ICU Absent Absent Absent Absent Absent 9.6 29300 300000 129 3.6 7.2 4 Absent Absent Absent 3.7
29 11/03788 SARASWATHI 64 Female ICU Absent Absent Absent Absent Absent 8.8 13500 307000 131 6.5 7.34 1 Absent Absent Absent 4.5
30 11/10025 SUBRAMANI 47 Male Not ICU Absent Absent Absent Present Absent 11.4 14800 413000 132 3.7 7.34 0.8 Absent Absent Absent 14.9
31 11/09969 SARASATHAL 54 Female ICU Absent Absent Present Absent Present 15.9 21000 419000 149 4.7 7.06 4.2 Absent Present Present 4.3
32 11/09661 GNANASEKARAN 29 Male ICU Absent Absent Absent Absent Absent 11.1 18300 518000 130 5.8 7.3 7.5 Present Present Present 4.2
33 11/09458 FALLIA 41 Female ICU Absent Absent Present Absent Absent 7.1 14700 300000 138 4.3 7.3 3.3 Absent Absent Absent 7.3
34 11/08748 SUBASH CHANDRA BOSE36 Male ICU Absent Absent Absent Absent Absent 10.8 20500 640000 130 4.1 7.34 2 Absent Present Present 4.9
35 11/08712 GANGAMMAL 60 Female ICU Absent Absent Absent Absent Absent 13.4 26000 577000 140 3.3 7.1 2.3 Present Present Present 4.7
36 11/08685 LEENUS 56 Male Not ICU Absent Absent Present Absent Present 12.4 12500 29000 131 3.1 7.2 4.2 Present Present Present 5.8
37 11/08398 VENUGOPAL 62 Male ICU Absent Absent Absent Absent Absent 10.1 21300 157000 138 3.1 7.4 5.2 Absent Present Present 3.2
38 11/06729 RAMYA 24 Female ICU Absent Absent Absent Absent Absent 11 36300 119000 136 3.6 7.1 5 Present Present Present 3.08
39 11/06713 HARISH 18 Male Not ICU Absent Absent Absent Absent Absent 10.9 9900 130000 143 4.8 7.34 0.8 Absent Absent Absent 3.3
40 11/05416 MANONMANI 57 Female Not ICU Absent Absent Absent Present Absent 11.4 18100 167000 121 4.8 7.34 1.9 Absent Absent Absent 5.4
41 11/05841 VENUGOPAL 56 Male Not ICU Absent Absent Present Absent Absent 10.4 16200 268000 134 7 7.24 0.8 Absent Absent Absent 8.3
42 11/08206 JOSEPH 82 Male Not ICU Absent Present Present Present Present 10.8 27900 112000 116 4.8 7.24 2.4 Absent Absent Absent 4.8
43 11/07188 PARAMASIVAM 47 Male ICU Absent Present Absent Present Absent 10.9 13200 276000 130 4.8 7.3 1.3 Absent Absent Absent 7.8
44 11/06990 CHINNASAMY 43 Male Not ICU Absent Absent Absent Absent Absent 9.1 22600 46000 136 6.6 7.34 1.2 Absent Absent Absent 10.9
45 11/06902 VENKATALAXMI 74 Female ICU Absent Absent Absent Absent Absent 12.7 6500 72000 132 3.4 7.4 2.4 Present Present Present 1.8
46 11/11713 JACOB 34 Male ICU Absent Absent Absent Present Absent 9.8 9400 232000 126 5.8 7.3 0.6 Absent Absent Absent 7.9
47 11/11496 SIVAKUMAR 37 Male ICU Absent Absent Absent Absent Absent 14.5 10400 147000 122 3.5 7.1 9 Present Present Present 14
48 11/11245 RESHMA 38 Male ICU Absent Absent Absent Absent Absent 10.4 37000 130000 130 4.7 7.34 4.6 Present Present Present 3.5
49 11/11824 KAUSHIK 19 Male ICU Absent Absent Absent Absent Absent 12.3 9800 397000 146 5.1 7.2 2.8 Present Present Present 4.5
50 11/11729 YOGINI 68 Female Not ICU Absent Absent Absent Absent Absent 12.9 17300 240000 140 3.9 7.1 10 Present Present Present 3.4
51 11/12698 RAJAMANI 74 Male ICU Absent Present Present Absent Absent 10.8 15800 333000 128 4.6 7.3 2.3 Present Present Present 1.6
52 11/12257 SARAVANA KUMAR 32 Male ICU Absent Absent Absent Absent Absent 19.6 15300 44000 140 5.6 7.2 4.7 Present Present Present 3.5
53 11/13069 DAKSHAYANI 60 Female ICU Absent Absent Absent Absent Absent 14 24100 301000 141 3.3 7.1 4.2 Absent Absent Absent 4.6
54 11/13965 SEKHAR 53 Male Not ICU Absent Absent Absent Absent Absent 13.4 15600 244000 133 3.4 7.3 0.8 Absent Absent Absent 7.9
55 11/14917 KANNIKIDEVI 45 Female ICU Absent Absent Present Absent Present 13.1 19800 142000 160 4.3 7.3 2.5 Absent Absent Absent 3.8
56 11/14516 DAMODARAN 76 Male Not ICU Absent Absent Absent Absent Absent 10.7 24400 229000 138 5.4 7.4 2.6 Absent Absent Absent 4.9
57 11/15501 GOVINDAN 43 Male Not ICU Absent Absent Present Present Absent 10.8 12500 150000 135 4.8 7.3 0.8 Absent Absent Absent 6.08
58 11/11175 RAYAPPAN 72 Male ICU Absent Absent Present Absent Absent 9.9 22300 73000 155 4.4 7.2 9.5 Present Present Present 3.6
59 11/07866 ARMUGAM 65 Male Not ICU Absent Absent Absent Absent Absent 5.9 20000 129000 132 4.4 7.3 3.6 Present Absent Absent 10.6
60 11/16766 PERIYASAMY 56 Male ICU Absent Absent Absent Present Absent 11.4 11200 132000 128 4.1 7.34 0.8 Absent Absent Absent 6.7
61 11/16769 SAYAMMAL 80 Female ICU Absent Absent Absent Absent Absent 8.8 14900 12000 135 4.1 7.3 0.8 Absent Present Present 4.7
62 11/16537 SIVARAJ 28 Male ICU Absent Present Absent Absent Absent 11.7 19100 102000 138 2.7 7.1 15 Absent Present Present 3.9
63 11/17188 KOMALA DEVI 43 Female Not ICU Absent Absent Absent Absent Absent 6.6 18100 225000 138 3.8 7.3 3 Absent Absent Absent 5.8
64 11/18200 MALLIKA JAN 54 Female Not ICU Absent Absent Present Absent Absent 5.4 13600 420000 130 7.2 7.2 4 Absent Absent Absent 6.3
65 11/18749 KRISHNAVENI 54 Female ICU Absent Absent Absent Absent Absent 11.2 16000 54000 138 4.1 7.3 2.4 Present Present Present 3.2
66 11/12855 DURAISAMY 59 Male ICU Present Absent Absent Absent Absent 6.1 13600 60000 130 7.5 7.1 6 Absent Present Present 5.8
67 11/07928 PRAKASH 23 Male ICU Present Absent Absent Absent Absent 11 12300 32000 132 6.1 7 12 Present Present Present 2.9
68 11/01127 CHANDRASEKAR 45 Male ICU Present Absent Absent Absent Absent 9.3 27500 263000 131 4.7 7.1 8 Present Present Present 3.7
69 11/10222 DEVARAJ 60 Male ICU Present Absent Absent Absent Absent 14.6 18100 251000 116 4.8 7.4 1.8 Present Present Present 3.9
70 11/12210 KANNAMMAL 76 Female ICU Absent Absent Absent Present Absent 8.6 26000 86000 134 8.2 7.4 2.6 Present Present Present 2.04
71 11/13659 BALASUBRAMANYAM 62 Male ICU Present Absent Absent Absent Absent 10.8 23400 116000 130 4.3 7.4 3.5 Present Present Present 5.3
72 11/11107 RAMASAMY 39 Male ICU Present Absent Absent Absent Absent 10.6 16000 110000 122 5.7 7.2 11 Absent Present Present 2.9
73 11/13156 SIVAM 68 Male ICU Absent Absent Absent Absent Absent 13 19800 147000 145 3.6 7 3 Present Present Present 4.1
74 11/19517 SUNEEL 41 Male ICU Present Absent Absent Absent Absent 12.9 12600 150000 137 3.6 7.3 3.3 Present Absent Absent 3.8
75 11/19989 NABEESHA 56 Female Not ICU Absent Absent Present Absent Absent 10.5 13000 351000 134 4.9 7.3 0.8 Absent Absent Absent 5.6
76 11/20075 RAMASAMY 68 Male ICU Absent Absent Absent Absent Absent 10.7 20000 150000 124 8.8 7.2 1.2 Present Absent Absent 12.5
77 11/20443 RUKMINI 64 Female Not ICU Absent Absent Present Absent Absent 11.9 11800 250000 127 3.6 7.3 0.8 Absent Absent Absent 7.6
78 11/18253 VENKATESH 40 Male ICU Present Absent Absent Present Absent 8.3 5400 69000 140 4.2 7.3 0.8 Absent Absent Absent 3.8
79 11/12845 BAGYALAXMI 37 Female ICU Absent Absent Absent Absent Absent 11.2 24200 124000 134 4.5 7.1 19 Present Present Present 3.5
80 11/07710 RANI KUMAR 47 Male ICU Present Absent Present Absent Absent 13.3 52000 23000 134 3.6 7.2 19 Present Present Present 2.7
81 11/05404 MAHENDRAN 43 Male ICU Absent Absent Present Absent Absent 9 10900 309000 129 4.6 6.8 16 Present Present Present 9.1
82 11/03185 MARIYAMMAL 45 Female ICU Absent Present Absent Absent Absent 12.6 10300 195000 134 4.2 7 11 Present Present Present 4.2
83 11/03127 BASHEER AHMED 77 Male ICU Absent Absent Absent Absent Absent 15 35000 221000 132 5 7.4 2.5 Present Present Present 8.7
84 11/01108 GANGUSAMY 89 Male ICU Absent Present Absent Present Absent 14.4 8900 199000 135 4.5 7.3 3.3 Present Present Present 2.7
85 11/01238 SUBRAM AN 51 Male ICU Present Absent Absent Absent Absent 11 18000 82000 137 4.1 7.2 5.6 Present Present Present 2.4
86 11/01116 BANUMATHI 81 Female ICU Absent Absent Absent Absent Absent 13.9 10500 267000 130 3.9 7.3 1.7 Present Present Present 2.9
87 11/03372 NATHESH 67 Male Not ICU Absent Present Absent Present Absent 10.3 7200 138000 120 4.7 7.3 2.5 Absent Absent Absent 7.1
88 11/01467 MANIVASAGAM 51 Male ICU Absent Absent Absent Absent Absent 16 20800 84000 134 4.8 7.1 11 Absent Present Present 4.9
89 11/15989 PARVATHINADAN 62 Male ICU Absent Present Present Present Absent 12.9 11500 81000 121 4.8 7.3 7.3 Absent Absent Absent 3.6
90 11/15847 MESHAM 65 Male ICU Absent Absent Present Absent Absent 7.6 22000 355000 116 5.9 7.3 3 Absent Present Present 5
91 11/01389 EBENRAJ 57 Male ICU Absent Absent Absent Absent Absent 10 19100 120000 130 5.9 7.2 12 Present Present Present 5
92 11/16177 KANDASAMY 55 Male ICU Absent Absent Absent Absent Absent 10 15000 106000 132 5.3 7.2 10 Present Present Present 7
93 11/05032 USHA 28 Female ICU Absent Absent Absent Absent Absent 10.9 12900 100000 133 7.5 7.3 0.8 Absent Absent Absent 7.1
94 11/18357 RUKMINI 75 Female ICU Absent Absent Absent Present Absent 10.8 22000 60000 132 4.9 7.3 7.9 Absent Present Present 2.8
95 11/17378 AMALRAJ 46 Male ICU Absent Absent Absent Absent Absent 16 15600 185000 141 3.6 7.2 2 Present Present Present 8.5
96 11/05693 ARMUGAM 50 Male ICU Absent Present Absent Absent Absent 10.9 4800 233000 127 5.2 7.3 10 Absent Present Present 4.5
97 11/00084 SRINIVASAN 55 Male ICU Absent Absent Present Absent Absent 12.3 16600 22000 140 3.1 7.1 6.4 Present Present Present 2.6
98 11/00144 SUBRAMANI 61 Male ICU Absent Present Present Present Absent 10.4 17000 225000 129 6.7 7 10 Present Present Present 12
99 10/52967 MARAGADAM 57 Female Not ICU Absent Present Present Absent Absent 9.6 9900 176000 125 2.5 7.4 0.8 Absent Absent Absent 2.7
100 11/01284 SIVARAJ 30 Male Not ICU Absent Absent Absent Absent Absent 17.5 25200 353000 133 4.7 7.24 2 Absent Absent Absent 5.3
101 11/01787 NALLASAMY 50 Male Not ICU Absent Absent Absent Absent Absent 10.4 29000 102000 121 7.1 7.4 0.8 Absent Absent Absent 6.2
102 11/01836 SRISOUNDARYA 24 Female ICU Absent Absent Absent Absent Absent 10.2 83000 83000 135 3.5 7.07 16.5 Present Present Present 3.2
103 11/01470 SELVI 54 Female ICU Absent Absent Absent Absent Absent 8.2 12900 139000 121 4.1 7.3 0.8 Absent Absent Absent 5.1
104 11/01478 VETRIVEL 49 Male ICU Absent Absent Present Absent Absent 10 23000 50000 132 6.01 7.4 2.8 Absent Present Present 5.2
105 11/01046 JOHN BERNABAS 58 Male ICU Absent Absent Present Absent Absent 16 14900 216000 135 4.6 7.24 0.8 Absent Present Present 6.5
106 11/01058 VENKATACHALAM 38 Male ICU Absent Absent Absent Absent Absent 12 38500 59000 132 3.5 7.3 6.3 Present Present Present 3.2
107 11/01876 KRISHNAN 71 Male ICU Absent Present Absent Absent Absent 10.1 9900 190000 127 8.2 7.4 0.8 Absent Present Present 3.5
108 11/00358 KRISHNAMMAL 77 Female Not ICU Absent Absent Present Absent Absent 10.2 15700 361000 136 4.6 7.4 0.8 Absent Present Present 2.6
109 11/02074 RAJALAXMI 55 Female ICU Absent Absent Absent Absent Absent 10.3 3600 28000 135 5 7.3 2 Absent Absent Absent 5.3
110 11/02803 INDRANI 26 Female ICU Absent Absent Absent Absent Absent 10.4 32600 153000 138 4.1 7.2 9.8 Absent Absent Absent 3.9
111 11/02857 SIVA 42 Male Not ICU Present Absent Absent Absent Absent 9.9 22500 115000 108 7.1 7.2 10 Absent Absent Absent 2.4
112 11/02785 RAMMURTHY 40 Male ICU Absent Absent Present Absent Absent 14.7 14400 62000 128 6.7 7.3 2.5 Absent Absent Absent 2.4
113 11/03266 KANDASAMY 43 Male Not ICU Absent Absent Absent Absent Absent 10.3 9000 250000 133 3.1 7.4 0.8 Absent Absent Absent 6.8
114 11/03048 PALANYSAMY 54 Male ICU Absent Present Absent Absent Absent 15.8 5100 182000 112 7.2 7.3 3 Absent Present Present 2
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disease Drugs Obstruction Post CABG Snake bite
Following                    
major                            
surgery Pancreatitis Malaria
Pregnancy        
related Rhabdomplysis OUTCOME
DURATION OF               
HOSPITAL                                 
STAY(Days)
DURATION 
OF        
DIALYSIS  
(Days)         
0.5 15 Present Surgery Absent Absent Absent Absent Absent Absent Absent Present Absent Absent Absent Absent Absent Absent Recovered 10 2
0.5 15 Absent Medicine Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Recovered 8 3
5 15 Present Medicine Present Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Recovered 15 8
0.5 15 Absent Medicine Present Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Recovered 20 10
1.7 13 Present Medicine Present Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Recovered 10 4
0.5 15 Absent Medicine Absent Absent Absent Absent Absent Present Absent Absent Absent Absent Absent Absent Absent Absent Recovered 15 8
0.5 15 Present Medicine Absent Absent Absent Absent Present Absent Absent Absent Absent Absent Absent Absent Absent Absent ESRD 14 90
0.5 15 Absent Medicine Absent Present Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Recovered 12 4
4 12 Present Medicine Present Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Recovered 14 4
0.3 10 Present Medicine Present Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Non Survivors 3 2
2 10 Present Medicine Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Present Absent Absent Recovered 14 4
0.5 15 Present Surgery Absent Absent Absent Absent Absent Absent Present Absent Absent Absent Absent Absent Absent Absent Recovered 10 20
4.2 6 Present Medicine Absent Absent Absent Absent Absent Absent Absent Absent Present Absent Absent Absent Absent Absent Non Survivors 4 2
4.5 15 Absent Medicine Absent Absent Absent Absent Absent Absent Present Absent Absent Absent Absent Absent Absent Absent Recovered 16 14
0.5 15 Present Medicine Absent Present Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Recovered 9 5
0.5 15 Absent Medicine Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Recovered 5 2
0.5 15 Present Medicine Present Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Recovered 20 40
0.5 15 Present Surgery Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Present Recovered 30 60
0.5 10 Present Medicine Present Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Non Survivors 4 2
0.5 15 Present Medicine Absent Absent Absent Absent Present Absent Absent Absent Absent Absent Absent Absent Absent Absent ESRD 15 90
2.3 10 Present Surgery Absent Absent Absent Absent Absent Absent Absent Absent Absent 1Absent Absent Absent Absent Absent Non Survivors 14 10
2.4 15 Present Medicine Absent Absent Absent Present Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Non Survivors 2 2
0.5 15 Absent Surgery Absent Absent Absent Absent Absent Absent Present Absent Absent Absent Absent Absent Absent Absent Recovered 15 10
0.5 15 Present Medicine Absent Present Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Recovered 5 10
1.7 12 Present Medicine Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Present Absent Absent Absent Recovered 35 60
0.5 15 Present Medicine Present Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Recovered 10 7
0.5 12 Present Medicine Absent Absent Absent Absent Present Absent Absent Absent Absent Absent Absent Absent Absent Absent Non Survivors 10 10
29 15 Present Medicine Present Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Non Survivors 15 3
6.1 12 Present Medicine Present Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Recovered 10 10
0.5 15 Absent Surgery Absent Absent Absent Absent Absent Absent Present Absent Absent Absent Absent Absent Absent Absent Recovered 10 5
2 12 Present Medicine Absent Present Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Recovered 10 20
0.7 15 Present Medicine Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Present Absent Absent Absent Recovered 20 30
0.5 15 Present Medicine Present Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Recovered 7 4
0.5 15 Present Medicine Absent Present Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Recovered 5 4
2 10 Present Medicine Present Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Non Survivors 2 1
1.6 8 Present Medicine Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Present Absent Absent Recovered 11 10
1.2 12 Present Surgery Present Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Recovered 7 10
4.7 12 Present OBG Present Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Recovered 13 10
0.8 15 Present Medicine Absent Absent Absent Absent Present Absent Absent Absent Absent Absent Absent Absent Absent Absent Recovered 8 4
1.5 15 Present Medicine Present Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Non Survivors 10 5
1.2 15 Present Surgery Absent Absent Absent Absent Absent Absent Present Absent Absent Absent Absent Absent Absent Absent Recovered 10 4
0.8 15 Present Medicine Present Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Recovered 10 4
0.8 15 Absent Medicine Present Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Recovered 6 4
0.5 15 Present Medicine Present Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Recovered 7 20
0.7 12 Present Medicine Present Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Recovered 30 4
0.5 15 Present Medicine Absent Absent Absent Absent Present Absent Absent Absent Absent Absent Absent Absent Absent Absent ESRD 7 90
0.5 8 Present Medicine Absent Present Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Non Survivors 9 9
3.9 8 Present Surgery Absent Absent Absent Absent Absent Absent Absent Absent Absent 1Absent Absent Absent Absent Absent Non Survivors 4 2
2.3 10 Present Medicine Present Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Non Survivors 6 4
2.4 8 Present Surgery Absent Absent Absent Absent Absent Absent Absent Absent Absent 1Absent Absent Absent Absent Absent Non Survivors 20 12
0.5 15 Present Surgery Absent Absent Absent Absent Absent Absent Absent Present Absent Absent Absent Absent Absent Absent Recovered 16 6
3.1 10 Present Medicine Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Present Absent Absent Absent Non Survivors 2 2
0.5 15 Present Medicine Absent Present Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Recovered 7 5
0.5 15 Present Medicine Absent Absent Absent Absent Present Absent Absent Absent Absent Absent Absent Absent Absent Absent Recovered 7 28
0.8 15 Present Medicine Present Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Recovered 10 14
4.8 15 Absent Medicine Present Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Recovered 20 8
0.5 15 Present Medicine Absent Present Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Recovered 7 7
0.5 10 Present Medicine Present Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Non Survivors 2 2
1.2 15 Present Medicine Present Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Non Survivors 50 30
0.5 15 Present Medicine Present Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Recovered 15 5
0.8 15 Present Medicine Present Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Recovered 15 7
4 15 Present Medicine Absent Absent Absent Present Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Non Survivors 14 10
0.6 15 Present Medicine Present Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Recovered 18 18
0.5 15 Absent Medicine Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Recovered 10 4
6.5 8 Present Medicine Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Present Absent Absent Recovered 9 9
6.2 8 Present Medicine Absent Absent Present Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Non Survivors 2 2
23 8 Present Medicine Absent Absent Present Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Non Survivors 2 2
30 5 Present Medicine Absent Absent Present Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Non Survivors 4 3
32 8 Present Medicine Absent Absent Present Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Non Survivors 14 2
1.6 10 Present Medicine Present Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Non Survivors 15 5
8.5 12 Present Medicine Absent Absent Present Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Non Survivors 23 23
19.5 10 Present Medicine Absent Absent Present Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Non Survivors 18 10
0.9 12 Present Medicine Present Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Non Survivors 17 10
4.8 15 Absent Medicine Absent Absent Present Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Recovered 32 10
0.5 15 Present Medicine Present Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Recovered 14 5
0.5 10 Present Medicine Present Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Non Survivors 20 20
0.5 15 Present Medicine Present Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Recovered 10 4
8 15 Present Medicine Absent Absent Present Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Recovered 24 10
5.3 5 Present Medicine Present Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Non Survivors 2 2
11.3 10 Present Medicine Absent Absent Present Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Non Survivors 2 2
0.8 8 Present Medicine Absent Present Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Non Survivors 2 2
5 10 Present Medicine Absent Absent Absent Present Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Non Survivors 19 19
0.8 10 Present Surgery Absent Absent Absent Absent Absent Absent Absent Absent Absent 1Absent Absent Absent Absent Absent Non Survivors 5 5
5 12 Present Medicine Absent Absent Absent Present Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Non Survivors 13 5
3.8 10 Present Medicine Absent Absent Present Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Non Survivors 2 2
0.5 12 Present Medicine Present Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Non Survivors 13 5
4 15 Present Medicine Absent Absent Absent Present Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Non Survivors 10 10
6.1 12 Present Medicine Present Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Non Survivors 2 2
3.1 15 Present Medicine Absent Absent Absent Present Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Recovered 14 8
0.8 15 Present Surgery Present Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Recovered 10 5
5 8 Present Medicine Present Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Non Survivors 3 3
2 8 Present Medicine Absent Absent Absent Absent Absent Absent Absent Absent Present Absent Absent Absent Absent Absent Non Survivors 13 13
0.8 15 Present Medicine Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Present Recovered 18 30
5.3 15 Present Medicine Present Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Non Survivors 2 2
4.1 3 Present Surgery Present Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Non Survivors 10 2
5 12 Present Medicine Absent Absent Absent Present Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Non Survivors 10 5
5.6 8 Present Medicine Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Present Absent Absent Non Survivors 22 22
0.8 6 Present Medicine Present Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Non Survivors 24 24
4 15 Present Medicine Absent Absent Absent Present Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Recovered 30 10
0.5 15 Present Medicine Absent Present Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Recovered 12 20
3.4 15 Absent Medicine Present Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Recovered 10 7
3.7 8 Present Medicine Present Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Non Survivors 10 10
0.5 15 Present Medicine Absent Absent Absent Absent Present Absent Absent Absent Absent Absent Absent Absent Absent Absent ESRD 8 90
14.9 15 Present Medicine Present Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Non Survivors 5 5
0.5 15 Present Medicine Absent Present Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Recovered 20 42
4.5 12 Present Medicine Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Present Absent Absent Absent Non Survivors 3 3
1.7 15 Present Medicine Absent Absent Absent Present Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Non Survivors 7 3
0.5 15 Absent Surgery Present Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Recovered 30 20
4.7 15 Present Medicine Present Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Recovered 9 9
13 15 Absent OBG Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Present Absent Recovered 23 30
9.2 12 Present Medicine Absent Absent Present Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Non Survivors 10 10
0.5 15 Absent Medicine Present Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Recovered 22 15
0.5 15 Absent Surgery Absent Absent Absent Absent Absent Absent Present Absent Absent Absent Absent Absent Absent Absent Recovered 9 3








A STUDY OF FACTORS DETERMINING OUTCOME OF ACUTE RENAL 
FAILURE PATIENTS REQUIRING HEMODIALYSIS 
 
ABSTRACT: 
Background: Acute renal failure is a common problem in critically ill patients and usually   
associated with significant morbidity and a high mortality rate. Despite advances in the 
management of critically ill patients with acute kidney injury (AKI), the prognosis is poor.  
Aim: To ascertain the causes and outcomes of acute renal failure requiring renal replacement 
therapy. 
Design: A prospective observational study of patients with acute renal failure treated with IHD 
in one teaching tertiary care hospital  from November 2010 to 31 Oct 2011 .The  outcomes 
measured  was hospital mortality and progression to ESRD  and  dialysis dependency 
Relationship between demographics, premorbidities and clinical parameters with outcome was 
studied. 
Measurements and results: One hundred and fourteen patients were included in the final 
analysis. Of the 114 patients, 49 died (42.98%), 61 (53.5%) recovered to have normal renal 
function or mild renal dysfunction and 4 patients (3.5%) progressed to end state renal disease 
(ESRD) The  Mortality among patients admitted in ICU was 87.8%. Parameters directly related 








liver disease, preexisting heart disease, requirement of mechanical ventilation, oliguria, sepsis, 
hepatorenal syndrome cardiogenic shock, admission in ICU. 
 
Conclusion: ARF in ICU was associated with a high mortality rate. Patients with poor outcome 
were presence of chronic liver disease, preexisting heart disease hepatorenal syndrome and 
mechanical ventilation cardiogenic shock,. Most of the hospital survivors were free from 
dialysis. 
 
Key words: Acute renal failure, Intermittent haemodialysis, Outcome predictors 
 
 
 
 
 
 
 
